ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$834.06
Tradestie Score
57
Market Cap
$46.96B
P/E Ratio
33.7
Revenue Growth
0.6%
Analyst Upside
+29.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$762.14
|
$63.59B | 17.0 | 58 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$217.76
|
$60.38B | 71.8 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$311.41
|
$36.81B | 74.0 | 53 | Compare |
|
INSM
Insmed, Inc.
|
$98.26
|
$31.13B | - | 47 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$92.87
|
$24.57B | - | 51 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.65
|
$19.56B | 21.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$118.99
|
$16.93B | 16.2 | 59 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.24
|
$15.70B | 31.2 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.14
|
$15.22B | - | 57 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$245.15
|
$12.36B | 29.2 | 54 | Compare |
More ARGX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry